UBS Group »

CNS Pharmaceuticals shares owned by UBS Group

Quarter-by-quarter ownership of CNS Pharmaceuticals (CNSP) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in CNS Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including CNS Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in CNS Pharmaceuticals by UBS Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $95k 11k 9.00

More positions owned by UBS Group

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Ubs Group SHS (UBS)
Tesla Motors (TSLA)
Ishares Tr Russell 2000 Etf (IWM)
Visa Com Cl A (V)

View all positions for UBS Group

Top funds holding CNS Pharmaceuticals

DRW Holdings
UBS Group
Barrett & Company
MAI Wealth Advisors
Danske Bank A/s

View all funds holding CNS Pharmaceuticals